ChartRow logo
Share this page
HIMS
$28.07-4.46%
as of close, Oct 16, 2026
☾ AH $28.07 -4.46%
Hims & Hers Health Inc.Stock · HealthcareRussell 2000 0.2%US Stock Market 0.01%Russell 3000 0.010%
PeersMRNALLYMDTUNHJNJTMO

HIMS financial statements

The full income statement, balance sheet, and cash-flow statement for Hims & Hers Health Inc. (HIMS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 234.8M2024-09 235.1M2024-12 247.8M2025-03 246.6M2025-06 256.8M2025-09 248.7M2025-12 266.3M2026-03 228.4M2026-06 233.3M-0.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue2.35B+59.0%1.48B+69.3%872M+65.5%527M+93.8%272M+82.8%
1.73B+47.8%1.17B+64.1%715M+74.9%409M+99.9%204M+86.8%
Cost of revenue614M+102.5%303M+93.2%157M+32.9%118M+75.4%67.4M+71.4%
1.63B+46.5%1.11B+49.3%744M+55.9%477M+49.4%320M+156.5%
Selling, general & administrative273M+62.6%168M+29.2%130M+32.3%98.2M-46.5%184M+179.9%
General & administrative273M+62.6%168M+29.2%130M+32.3%98.2M-13.6%114M+336.6%
Selling & marketing919M+35.4%679M+52.1%446M+63.8%273M+100.6%136M+130.4%
Amortization of intangibles23.7M+523.7%3.80M+8.6%3.50M-14.6%4.10M+95.2%2.10M+2000.0%
Operating income106M+70.6%61.9M+310.2%-29.5M+57.1%-68.7M+40.3%-115M-659.7%
Interest expense
————0.00-100.0%
Other non-operating income23.1M+135.8%9.81M+9.5%8.96M+207.0%2.92M+555.7%445K+115.7%
Gain (loss) on equity securities4.40M0.000.00——
Pre-tax income124M+72.8%71.7M+432.4%-21.6M+67.2%-65.7M+40.7%-111M-516.0%
Income tax-4.44M+91.8%-54.3M-2850.7%1.98M+6471.0%-31.0K+99.0%-3.14M-2569.3%
Net income128M+1.8%126M+635.3%-23.5M+64.1%-65.7M+39.0%-108M-494.3%
$0.51-3.8%$0.53+581.8%-$0.11+65.6%-$0.32+44.8%-$0.58-13.7%
EPS (basic)$0.57-1.7%$0.58+627.3%-$0.11+65.6%-$0.32+44.8%-$0.58-13.7%
Weighted-avg shares (basic)225M+4.2%216M+3.1%209M+2.4%205M+9.5%187M+428.3%
Weighted-avg shares (diluted)258M+9.0%237M+13.1%209M+2.4%205M+9.5%187M+428.3%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
768M+93.9%396M+49.3%265M+22.4%217M-19.8%270M+138.7%
Cash & equivalents229M+3.6%221M+128.2%96.7M+106.7%46.8M-34.8%71.8M+162.5%
Accounts receivable32.1M+426.2%6.10M-9.0%6.70M+71.8%3.90M-4.9%4.10M+272.7%
Inventory80.1M+24.4%64.4M+186.8%22.5M+4.2%21.6M+59.0%13.6M+282.7%
Prepaid expenses77.9M+150.0%31.2M+44.2%21.6M+40.2%15.4M+69.8%9.07M+67.9%
Other current assets4.37M+993.5%400K-90.5%4.20M+135.0%1.78M+100.6%890K-54.7%
2.15B+204.5%708M+60.4%441M+20.4%366M-12.9%421M+254.3%
Property, plant & equipment———3.00M+36.4%2.20M+29.4%
Operating lease right-of-use137M+1159.5%10.9M+13.5%9.59M+94.2%4.94M-3.4%5.11M
Goodwill278M+146.9%113M+1.7%111M+0.0%111M+0.0%111M
Intangible assets196M+351.8%43.4M+133.7%18.6M-15.0%21.8M-15.6%25.9M-56.1%
Long-term investments
—0.00———
Deferred tax assets82.7M+34.3%61.6M0.00——
Other non-current assets29.7M+20090.5%147K+61.5%91.0K-99.7%33.0M+315.5%7.94M+74.6%
404M+82.7%221M+150.2%88.5M+84.5%47.9M-39.5%79.2M+420.2%
Accounts payable143M+57.1%91.2M+111.7%43.1M+33.1%32.4M+64.8%19.6M+143.5%
Accrued liabilities77.0M+45.3%53.0M+83.0%29.0M+132.7%12.4M+2.1%12.2M+144.7%
Deferred revenue127M+68.9%75.3M+873.6%7.73M+425.3%1.47M-53.8%3.19M+150.6%
Current lease liability4.84M+156.4%1.89M+47.5%1.28M-22.7%1.66M+21.5%1.36M
1.61B+599.1%231M+137.6%97.2M+77.9%54.6M-36.5%86.0M+450.7%
Non-current lease liability143M+1414.0%9.46M+9.1%8.67M+137.5%3.65M-11.4%4.12M
Operating lease liability (total)148M+1204.6%11.3M+14.0%9.95M+87.5%5.31M-3.2%5.48M
Deferred tax liabilities28.9M0.00———
Other non-current liabilities6.25M0.00-100.0%22.0K-37.1%35.0K-94.4%629K+65.1%
541M+13.5%477M+38.6%344M+10.4%312M-6.8%335M+327.8%
Common stock23.0K+4.5%22.0K+4.8%21.0K+0.0%21.0K+5.0%20.0K+300.0%
Additional paid-in capital652M-9.3%719M+1.0%712M+8.5%657M+7.0%614M+8792.6%
Retained earnings-114M+53.0%-242M+34.2%-368M-6.8%-345M-23.5%-279M-62.9%
Accumulated other comprehensive income2.29M+808.0%-324K-161.3%-124K+55.2%-277K-102.2%-137K-1145.5%
Total liabilities & equity2.15B+204.5%708M+60.4%441M+20.4%366M-12.9%421M+254.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
300M+19.5%251M+241.7%73.5M+377.0%-26.5M+22.9%-34.4M-1288.1%
Depreciation & amortization54.5M+218.9%17.1M+79.6%9.52M+27.3%7.47M+83.4%4.08M+285.5%
Intangible amortization23.7M+523.7%3.80M+8.6%3.50M-14.6%4.10M+95.2%2.10M+2000.0%
Share-based compensation135M+46.5%92.3M+39.7%66.1M+54.3%42.8M-36.3%67.2M+1052.6%
Deferred income taxes-13.0M+79.0%-61.6M-474123.1%-13.0K+97.8%-594K+82.5%-3.39M
Change in inventory13.7M-67.0%41.6M+4513.3%902K-88.7%8.00M-16.9%9.63M+1528.5%
Change in payables30.3M-30.7%43.7M+496.8%7.32M-42.4%12.7M+29.1%9.85M+1092.9%
-1.02B-5280.9%-19.0M-57.3%-12.1M-134.9%34.7M+122.2%-156M-293.6%
Capital expenditure243M+359.5%52.8M+99.2%26.5M+268.1%7.20M+765.4%832K-52.1%
Free cash flow57.4M-71.0%198M+322.0%47.0M+239.3%-33.7M+4.3%-35.2M-736.0%
Acquisitions145M+843.1%15.4M0.000.00-100.0%46.5M
Sales/maturities of investments109M-48.0%209M+22.9%170M-12.5%194M+22.7%158M+230.0%
730M+776.5%-108M-839.8%-11.5M+65.4%-33.1M-114.1%235M+392.3%
Long-term debt issued970M0.000.000.000.00
Long-term debt repaid0.000.000.000.000.00-100.0%
Common stock issued0.000.000.000.000.00
Common stock repurchased90.0M+8.3%83.0M+4054.0%2.00M0.000.00
Dividends paid0.000.000.000.000.00
FX effect on cash2.51M+1028.9%-270K-2354.5%-11.0K+79.2%-53.0K+27.4%-73.0K-711.1%
Net change in cash7.18M-94.2%124M+148.4%49.9M+299.5%-25.0M-156.5%44.3M+697.6%
Interest paid———0.000.00-100.0%
Income taxes paid23.2M+193.2%7.90M+618.2%1.10M+73.0%636K+88.2%338K+52.9%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap8.65B+44.3%5.99B+220.4%1.87B+42.2%1.32B-0.3%1.32B+155.6%
P/E67.4×+41.7%47.5×———
P/S3.7×-9.2%4.1×+72.0%2.4×-20.3%3.0×-39.0%4.9×+39.8%
P/B16.0×+27.2%12.6×+120.8%5.7×+34.5%4.2×+7.3%3.9×
P/FCF150.6×+398.4%30.2×———
Earnings yield1.5%-29.4%2.1%———
FCF yield0.66%-79.9%3.3%———
Source filing10-K10-K10-K10-K10-K

About this data

Source: HIMS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HIMS filings on SEC EDGAR → Not investment advice.